Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular membranes and tumor microvasculature represent broad physiological and structural compartments rather than specific molecular targets. The cellular membrane is a phospholipid bilayer that maintains cell integrity and regulates the movement of substances, while the tumor microvasculature is the complex network of blood vessels that develops to sustain tumor growth (National Cancer Institute, 2023). In therapeutic contexts, these structures are targeted by agents like photodynamic therapy (PDT) drugs, which localize to membranes and generate reactive oxygen species upon light activation, and vascular disrupting agents (VDAs), which selectively attack the established tumor blood supply (Tozer et al., Nature Reviews Cancer, 2005). Because this term describes a collection of diverse biological entities including lipids, proteins, and various cell types such as endothelial cells and pericytes, it is classified as a therapeutic site or environment (PubChem, 2024). Targeting these structures aims to induce direct cell death or indirect tumor necrosis by cutting off oxygen and nutrient supplies (StatPearls, 2023). Consequently, while these structures are critical to drug action, they lack the specificity of a single protein or gene target.
Mechanisms include the induction of oxidative damage to lipid bilayers via reactive oxygen species (ROS) and the rapid disruption of the endothelial cytoskeleton leading to vascular collapse and secondary tumor necrosis (PubMed, PMID: 15990908).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular membranes and tumor microvasculature.